Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fergal Casey

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Msphere|November 2, 2018
Interplay of Klebsiella pneumoniae <i>fabZ</i> and <i>lpxC</i> Mutations Leads to LpxC Inhibitor-Dependent Growth Resulting from Loss of Membrane HomeostasisMina Mostafavi, Lisha Wang, Lili Xie, et al.
Journal of Molecular Biology|February 22, 2023
RNASequest: An End-to-End Reproducible RNAseq Data Analysis and Publishing FrameworkJing Zhu, Yu H Sun, Zhengyu Ouyang, et al.
Scientific Reports|October 17, 2022
Characterizing the composition of iPSC derived cells from bulk transcriptomics data with CellMapZhengyu Ouyang, Nathanael Bourgeois-Tchir, Eugenia Lyashenko, et al.
Journal of Parkinson'S Disease|February 20, 2025
The effect of polygenic risk score on PD risk and phenotype in <i>LRRK2</i> G2019S and <i>GBA1</i> carriersOrly Goldstein, Shachar Shani, Mali Gana-Weisz, et al.
BMC Genomics|May 2, 2023
scRNASequest: an ecosystem of scRNA-seq analysis, visualization, and publishingKejie Li, Yu H Sun, Zhengyu Ouyang, et al.
Journal of Genetics and Genomics = Yi Chuan Xue Bao|March 19, 2021
PARK16 locus: Differential effects of the non-coding rs823114 on Parkinson's disease risk, RNA expression, and DNA methylationOrly Goldstein, Mali Gana-Weisz, Fergal Casey, et al.
Antimicrobial Agents and Chemotherapy|August 1, 2018
Mode of Action of the Monobactam LYS228 and Mechanisms Decreasing <i>In Vitro</i> Susceptibility in Escherichia coli and Klebsiella pneumoniaeCharles R Dean, David T Barkan, Alun Bermingham, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 26, 2026
Identification Of a Therapeutic Threshold For AAV-STXBP1 Gene Therapy in a Rodent Model of STXBP1 Developmental & Epileptic EncephalopathyNicholas B Gallo, John W Annand, Pete Clarner, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 20, 2024
Dorsal root ganglion toxicity after AAV intra-CSF delivery of a RNAi expression construct into non-human primates and miceZachary C E Hawley, Ingrid D Pardo, Shaolong Cao, et al.
Clinical & Translational Immunology|June 18, 2021
Next-generation Bruton's tyrosine kinase inhibitor BIIB091 selectively and potently inhibits B cell and Fc receptor signaling and downstream functions in B cells and myeloid cellsEris Bame, Hao Tang, Jeremy C Burns, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Msphere|November 2, 2018
Interplay of Klebsiella pneumoniae <i>fabZ</i> and <i>lpxC</i> Mutations Leads to LpxC Inhibitor-Dependent Growth Resulting from Loss of Membrane HomeostasisMina Mostafavi, Lisha Wang, Lili Xie, et al.
Journal of Molecular Biology|February 22, 2023
RNASequest: An End-to-End Reproducible RNAseq Data Analysis and Publishing FrameworkJing Zhu, Yu H Sun, Zhengyu Ouyang, et al.
Scientific Reports|October 17, 2022
Characterizing the composition of iPSC derived cells from bulk transcriptomics data with CellMapZhengyu Ouyang, Nathanael Bourgeois-Tchir, Eugenia Lyashenko, et al.
Journal of Parkinson'S Disease|February 20, 2025
The effect of polygenic risk score on PD risk and phenotype in <i>LRRK2</i> G2019S and <i>GBA1</i> carriersOrly Goldstein, Shachar Shani, Mali Gana-Weisz, et al.
BMC Genomics|May 2, 2023
scRNASequest: an ecosystem of scRNA-seq analysis, visualization, and publishingKejie Li, Yu H Sun, Zhengyu Ouyang, et al.
Journal of Genetics and Genomics = Yi Chuan Xue Bao|March 19, 2021
PARK16 locus: Differential effects of the non-coding rs823114 on Parkinson's disease risk, RNA expression, and DNA methylationOrly Goldstein, Mali Gana-Weisz, Fergal Casey, et al.
Antimicrobial Agents and Chemotherapy|August 1, 2018
Mode of Action of the Monobactam LYS228 and Mechanisms Decreasing <i>In Vitro</i> Susceptibility in Escherichia coli and Klebsiella pneumoniaeCharles R Dean, David T Barkan, Alun Bermingham, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 26, 2026
Identification Of a Therapeutic Threshold For AAV-STXBP1 Gene Therapy in a Rodent Model of STXBP1 Developmental & Epileptic EncephalopathyNicholas B Gallo, John W Annand, Pete Clarner, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 20, 2024
Dorsal root ganglion toxicity after AAV intra-CSF delivery of a RNAi expression construct into non-human primates and miceZachary C E Hawley, Ingrid D Pardo, Shaolong Cao, et al.
Clinical & Translational Immunology|June 18, 2021
Next-generation Bruton's tyrosine kinase inhibitor BIIB091 selectively and potently inhibits B cell and Fc receptor signaling and downstream functions in B cells and myeloid cellsEris Bame, Hao Tang, Jeremy C Burns, et al.
Pageof 3